| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/13/2009 | EP2057985A1 Coated tablet |
| 05/13/2009 | EP2057905A1 Composition for moderating Triglyceride and Cholesterol Levels |
| 05/13/2009 | EP2057284A1 Compositions and methods for the modulation of jnk proteins |
| 05/13/2009 | EP2057159A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/13/2009 | EP2057145A1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 05/13/2009 | EP2057137A1 R-(-) / s-(+)-7-[3-n-substituted amino-2-hydroxypropoxy]flavones |
| 05/13/2009 | EP2056830A1 Compositions useful especially for treatment or prevention of metabolic syndrome |
| 05/13/2009 | EP2056819A2 Cholesterol lowering drug combination |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 05/13/2009 | EP2056802A2 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 05/13/2009 | EP2056673A2 Combination treatment for metabolic disorders |
| 05/13/2009 | EP1893208B1 Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder |
| 05/13/2009 | EP1758565B1 Method of identifying GLP-1 secretagogues |
| 05/13/2009 | EP1515972B1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 05/13/2009 | EP1429770B1 New formulations and use thereof |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1377570B1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor |
| 05/13/2009 | EP1259474B1 Calcium dicarboxylate ethers, methods of making same |
| 05/13/2009 | CN101432277A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432275A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432265A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432263A Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432262A Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432256A Method for stabilization of reduced coenzyme Q10 |
| 05/13/2009 | CN101431998A Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators |
| 05/13/2009 | CN101431994A Use of CBx cannabinoid receptor modulators as potassium channel modulators |
| 05/13/2009 | CN101431993A Use of DHA and ARA in the preparation of a composition for regulating gene expression |
| 05/13/2009 | CN101429191A Uses of substituted tetrahydrochysene isoquinoline derivant |
| 05/13/2009 | CN101429183A 2H-1-benzopyran-2-ketone compounds with alpha-glucosidase inhibit activity, its composition and preparation method thereof |
| 05/13/2009 | CN101428137A Composition for diminishing neutral fat in blood |
| 05/13/2009 | CN101428136A Uses of recombinant protein in preparing oral medication for preventing diabetes |
| 05/13/2009 | CN101428132A Chinese medicinal composition for treating hyperlipemia and preparation thereof |
| 05/13/2009 | CN101428117A Medicament for invigorating pulse and reducing adipose, and preparation method thereof |
| 05/13/2009 | CN101428113A Traditional Chinese medicine preparation for treating type II diabetes and preparation method thereof |
| 05/13/2009 | CN101428110A Hypolipemic capsule of ginseng |
| 05/13/2009 | CN101428078A Tibetan medicine composition for governing blood fat and preparation thereof |
| 05/13/2009 | CN101428077A Traditional Chinese medicine composition for treating diabetes |
| 05/13/2009 | CN101428055A Uses of rhodiola rosea plants in medicament for preventing and treating diabetes and adiposis |
| 05/13/2009 | CN101428054A Uses of rhodiola rosea in preventing and treating insulin resistance, and correlated metabolism diseases |
| 05/13/2009 | CN101428041A Cordyceps sinensis extract, preparation method and uses in preparing medicament |
| 05/13/2009 | CN101428012A Medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 05/13/2009 | CN101428009A Insulin intranasal inhalation powder spray |
| 05/13/2009 | CN101428008A Simvastatin apellagrin sustained-release capsule and method of producing the same |
| 05/13/2009 | CN101428007A Process for producing diabecron sustained release tablet |
| 05/13/2009 | CN101428001A Preparation of O/W type medium chain fatty acid microemulsion |
| 05/13/2009 | CN101427777A Health care antilipemic tea in bags and method of producing the same |
| 05/13/2009 | CN100487064C Preparation process of squid ink black pigment and application thereof |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486983C Medicine compound for preventing diabets mellitus and preparing method thereof |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/13/2009 | CN100486611C Health-care foot-soaking liquid for diabetes and its preparation |
| 05/13/2009 | CN100486605C Big bitter gourd in application for preparing medication |
| 05/13/2009 | CN100486591C Traditional Chinese and western style oral composite nutrient formulation for treating type 2 diabetes |
| 05/13/2009 | CN100486579C Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486572C Medicament form of tatin class |
| 05/13/2009 | CN100486565C Hawthorm extract fat lowering dispersion tablet and its preparation technology |
| 05/12/2009 | US7531663 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 05/12/2009 | US7531576 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis |
| 05/12/2009 | US7531567 effector ambroxole with ACE inhibitors; treatment of a disturbance of the thiol-disulfide status in kidney replacement therapy |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531563 e.g. 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid; ferrochelatase; thalassemia, anemia; diagnosing and treating pathological conditions associated with excess of trivalent metals (such as Fe, Al and Cr) |
| 05/12/2009 | US7531561 GSK-3 inhibitors |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/12/2009 | US7531556 Compositions useful as inhibitors of rock and other protein kinases |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531512 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | CA2611659A1 Method for enhancing delivery and uniformity of concentration of dietary ingredients |
| 05/12/2009 | CA2484494C High dose ibandronate formulation |
| 05/12/2009 | CA2377301C Controlled release and taste masking oral pharmaceutical compositions |
| 05/12/2009 | CA2341973C Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid |
| 05/12/2009 | CA2303448C Specific steady-state r-type ca2+ channel blockers and use thereof |
| 05/12/2009 | CA2213254C Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/07/2009 | WO2009059048A2 (+)-opioids and methods of use |
| 05/07/2009 | WO2009058348A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | WO2009057796A1 Laxative agent |
| 05/07/2009 | WO2009057784A1 Heterocyclic compound |
| 05/07/2009 | WO2009057775A1 Anti-fatigue agent comprising amino acid composition |
| 05/07/2009 | WO2009057604A1 Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin |
| 05/07/2009 | WO2009057461A1 Therapeutic agent for diabetes |
| 05/07/2009 | WO2009057295A1 Lipid metabolism improver |
| 05/07/2009 | WO2009056983A1 New dha derivatives and their use as medicaments |
| 05/07/2009 | WO2009056737A2 Novel nacl salt substitute, use thereof and products containing same |
| 05/07/2009 | WO2009056707A2 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009056632A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 05/07/2009 | WO2009056255A1 Dough composition |
| 05/07/2009 | WO2009055867A1 Treatment of metabolic disease |
| 05/07/2009 | WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues |
| 05/07/2009 | WO2009033745A3 Use of a peptide as a therapeutic agent |
| 05/07/2009 | WO2009024287A3 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 05/07/2009 | WO2009023566A3 Method of treating autoimmune disease with mesenchymal stem cells |
| 05/07/2009 | WO2009018065A3 Novel glucokinase activators and methods of using same |
| 05/07/2009 | WO2008152068A3 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 05/07/2009 | WO2008108958A3 Benzimidazole derivatives and methods of use thereof |
| 05/07/2009 | WO2008077555A3 Substituted isoquinolines and their use as rho-kinase inhibitors |